Printer Friendly
The Free Library
19,607,059 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

CryoLife hit with 7 lawsuits over death of Minnesota man attributed to tainted tissue.


CryoLife has been hit with 7 separate lawsuits over the death late last year of a Minnesota man following knee surgery that was attributed to tainted tissue the patient received during the operation.

The family of Brian Lykins, 23, who died on November 11 after receiving a cartilage implant that was provided by a donor infected with a deadly bacterium-Clostridium sordelli-filed suite on July 12. The tissue was provided by CryoLife. Five other lawsuits connected with graft infections-2 in California and 3 in Tennessee-have been filed against the company, according to according to
prep.
1. As stated or indicated by; on the authority of: according to historians.

2. In keeping with: according to instructions.

3.
 the Associated Press.

In addition, CryoLife is the subject of a class action lawsuit class action lawsuit

A lawsuit in which one party or a limited number of parties sue on behalf of a larger group to which the parties belong. For example, investors may bring a class action lawsuit against a brokerage firm that has actively promoted a tax
 alleging the company knowingly made false and misleading statements regarding its quality control problems.

The suit, brought by the Philadelphia-based law firm of Berger & Montague, alleging securities fraud was filed in the US District Court for the Northern District of Georgia on behalf of all CryoLife shareholders between April 2, 2001 and July 5, 2002.

The complaint alleges the following:

*"Representatives from CryoLife told investors that the firm had never received a warning letter from the Food and Drug Administration (FDA FDA
abbr.
Food and Drug Administration


FDA,
n.pr See Food and Drug Administration.

FDA,
n.pr the abbreviation for the Food and Drug Administration.
). However, the FDA issued CryoLife a warning letter June 17 alleging, among other things, inadequate validation of various processes and procedures.

*CryoLife denied knowledge of fungal infection fungal infection, infection caused by a fungus (see Fungi), some affecting animals, others plants. Fungal Infections of Human and Animals
 resulting from use of its heart valves Heart valves
Valves that regulate blood flow into and out of the heart chambers.

Mentioned in: Heart Failure
 in a June 24 press release, despite being notified by the Centers for Disease Control and Prevention Centers for Disease Control and Prevention (CDC), agency of the U.S. Public Health Service since 1973, with headquarters in Atlanta; it was established in 1946 as the Communicable Disease Center.  (CDC See Control Data, century date change and Back Orifice.

CDC - Control Data Corporation
) in March that signs of fungal infection had been found in its culture of an explanted heart valve that CryoLife provided.

*The firm's denial of the problems caused the market price of CryoLife securities to be artificially inflated. However, shares of the firm's stock plummeted, from about $45 per share in April 2001 to $9.90 July 5, when the firm issued a press release admitting to receipt of a warning letter and 'additional information' from the CDC that showed that the explanted heart valves had signs of fungal infection."

CryoLife had not responded to the various lawsuits as Transplant News went to press.
COPYRIGHT 2002 Transplant Communications, Inc.
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2002 Gale, Cengage Learning. All rights reserved.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Comment:CryoLife hit with 7 lawsuits over death of Minnesota man attributed to tainted tissue.
Publication:Transplant News
Article Type:Brief Article
Geographic Code:1USA
Date:Jul 27, 2002
Words:342
Previous Article:NKF receives grant from MultiPlan to reprint transplant patient guide.
Next Article:Australia to allow xenotransplant research providing scientists follow stringent guidelines.
Topics:



Related Articles
CRYOLIFE REPORTS RECORD REVENUES FOR 1999 1ST QUARTER.
Deaths of 3 US transplant recipients from tainted organs, tissues fuels increased government oversight.
CryoLife receives warning letter from FDA following inspection of tissue processing labs.
CryoLife calls class action lawsuits "meritless," to offer "vigorous" defense against the charges.
CryoLife reeling from FDA order to recall soft tissue, SEC investigation.
CryoLife reaches agreement with FDA, which allows distribution of tissue deemed medically urgent.
FDA renews interim agreement with CryoLife, approves company's BioGlue facility.
CryoLife settles 5 product liability lawsuits, but says one insurer will not pay part of settlement.
CDC says clostridium infections were caused by musculoskeletal tissue allografts, more oversight needed.
CryoLife facing another lawsuit by a knee tissue recipient; says it will mount "vigorous defense".

Terms of use | Copyright © 2012 Farlex, Inc. | Feedback | For webmasters | Submit articles